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Lymphomas
Acute mucosal toxicity in supradiafragmatic irradiation of lymphomas
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Introduction. Radiotherapy has been the initial treatment for lymphomas, both Hodgkin’s disease (HD) and non-Hodgkin lym-
phoma (NHL). This treatment alone has shown to have high recurrence rates which justiﬁed the use of chemotherapy to achieve
better control of the disease. Data on the acute toxicity of the combined treatment are not always well documented. Studies tent
to focus on 3–4 toxicity grades, and do not detail grades 1–2 which are linked to a better the quality of life of patients.
Objectives. The main objective of this study is to describe the acute mucosal toxicity (pharyngeal and esophageal) of patients
treated with radiotherapy over volumes that include cervical nodal chains and/or mediastinal. Additionally, the study explores
possible relationships between the acute mucosal toxicity and factors related to the tumor, the patient and treatment.
Material and methods. To achieve that a retrospective study of 80 patients treated at The Radiation Oncology Department of The
Ramón y Cajal Hospital was carried out.
Results. The NHL and EH percentages were 32.5% and 67.5%, respectively. We use the NCI-CTCAE 4.0 for grading toxicity. It was
found that some type of mucosal toxicity was present in 81% of the cases with 36.3% being grade 1 and 41.3% being grade 2. Out
of those cases 18,8% required opioid analgesic treatment. The mean dose which began clinical mucositis was 17Gy. From the
different factors analyzed in this study it was found that mucosal toxicity levels are not related to histological type, gender, bone
marrow transplantation, different types of chemotherapy and number of cycles of chemotherapy.
Conclusions. In conclusion despite the low radiation dose used to treat lymphomas, mucosal toxicity levels were found in a large
number of patients even though they were exposed to low doses when compared to other types of tumors that require irradiation
of similar volumes.
http://dx.doi.org/10.1016/j.rpor.2013.03.333
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Introduction. There is a new concern about a possible association between Anaplastic Large Cell Lymphoma (ALCL) and breast
implants. We report a clinical case and make a review of all articles published concerning this subject between 1991 and 2011,
ﬁnding just 41 cases in the literature. Case A 51 years old woman with a previous history of breast cancer treated with chemother-
apy and radiotherapy to the right breast and with bilateral prostheses reconstruction developed, during the follow up, an axillary
lymphnode. The excisional biopsy of that node showedanALKnegativeALCL. The PET-TAC shows a focal increased of FDGuptake
at left axillar region and at the breast prosthetic ﬂuid area with no other pathological ﬁndings. The patient received 4 cycles of
CHOP (cyclophosphamide, doxorubicin and vincristine) chemotherapy, the prostheses was removed and then she received post-
operative adjuvant radiotherapy on the chest wall and regional lymph nodes to a total dose of 36Gy. Discussion Primary breast
lymphomas are, most of them, B-cell lymphomas but, reviewing the literature, we ﬁnd several cases of non-Hodgkin lymphoma
in women with breast implants, and these ones are mainly ALCL ALK negative which is a T-cell variant. Although the incidence
of this type of lymphoma remains remarkably low given that breast prostheses have been widely used for decades, clinical
and pathologic evidence for a causative role is becoming dramatically strong. Most of these patients underwent capsulectomy
since tumor cells are usually localized to the capsule or seroma. Capsulectomy may be also necessary for diagnostic purposes.
CHOP chemotherapy and local irradiation are recommended.Conclusions. None of the published studies managed to highlight a
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correlation between the prosthesis and this type of lymphoma. Surgical management seems to be essential for diagnosis and
treatment. Given the lack of data, treatment decisions need to be individualized.
http://dx.doi.org/10.1016/j.rpor.2013.03.334
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Introduction. The etiology lymphomatous is especially rare in this location. In 85% of cases of Hodgkin’s disease (HD) presents with
palpable lymphadenopathy. Most seated in the neck (60–80%), with a percentage epitrochlear <2%. Epitrochlear involvement in
Hodgkin disease is an uncommon event reported rarely in the literature. There is currently no clear consensus on the optimal
treatment technique for HD with epitrochlear involvement. Early-stage favorable HD, it may choose to perform after sequential
treatment with QT-RT or RT exclusive. Clinical case: 43-year-old-man with hypertension treated without other diseases. In
August 2011 have a growth on his left forearm without B symptoms, that after excision biopsy-diagnosed HD with lymphocyte-
predominant presence of adenopathy epitrochlear. It takes up study extension revealed the presence of axillary lymph nodes in
left, infraclavicular, supraclavicular and left submandibular. Diagnosed with HD lymphocyte-predominant E-IIA, chemotherapy
starts with ABDV scheme, receiving a total of 2 cycles and then given external radiotherapy with photons ALE 6 and 18MV in
region of left forearm epitrochlear more margin and cervical areas (Ia-IV), left axillary and supraclavicular fossa for a total of
30Gy. It takes a special locking system to place the forearm up and ensure proper coverage epitrochlear. The patient is being
monitored in the service of Hematology and Radiation Oncology. In PET-CT assessment is objective complete metabolic response
with no signs of tumor viability. Currently, the patient remains in complete response.
Conclusions. Epitrochlear involvement in HD is a rare event, with only limited data available describing this unique presentation,
its treatment, and long term outcome. In this case, since it was a stage HD early favorable, it was decided to chemotherapy and
radiotherapy to 30Gy sequentially, achieving complete tumor response.
http://dx.doi.org/10.1016/j.rpor.2013.03.335
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Introduction. Overall prognosis of patients with early-stage Hodgkin lymphoma is excellent, with 10 year overall survival >80%, but
second tumors remain the most important late effect, mostly breast cancer in female patients, so is of paramount importance
to decrease breast dose delivered in these patients. Traditionally these patients have been treated with APPA 3DRT. PURPOSE:
To evaluate different treatment options adopted in our department in order to better treat large volumes while sparing critical
organs.
Materials and methods. There is growing dosimetric evidence that highly conformal radiotherapy may spare critical organs in
lymphomas involving largemediastinal volumes, reducing radiationdose to lung, heart andbreast. To explore possible dosimetric
advantages of IMRT, 3 different options have been evaluated paying attention to improve conformality and minimizing low
radiation doses: 3DRT MLC, APPA Irregular Surface Compensator IMRT with manual ﬂuence shaping and VMAT.
Results. Decisions about choice of one technique over another were taken depending on the beneﬁcial effect in sparing surround-
ing normal tissue while preserving the precision of dose distribution. Illustrative examples of each option are included together
with the decision criteria.
Conclusions. To show our preliminary experience for lymphoma treatment with modern radiation techniques, initiating an open
debate for better technique choice. VMAT results in superior level of homogeneity and sparing organs at risk but increased low
radiation doses. Longer follow-up is needed to verify possible late toxicities.
http://dx.doi.org/10.1016/j.rpor.2013.03.336
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Introduction. Mycosis fungoides (MF) is the most frequent type of cutaneous T-cell lymphoma (CTCL) and is also frequently treated
withRT.A studyof very low-dose radiotherapy formycosis fungoideswith 8Gy in two fractions showed that the complete response
rate was 92%.
Purpose. To determine in our hospital that low-dose palliative radiotherapy is a useful and effective schedule of treatment.
